News about "in-licensing agreement"

Mankind Pharma In-Licenses Ensartinib from Betta Pharmaceuticals for India

Mankind Pharma In-Licenses Ensartinib from Betta Pharmaceuticals for India

Mankind Pharma enters into an exclusive in-licensing agreement with Betta Pharmaceuticals for Ensartinib, a targeted therapy for adults with ALK-positive locally advanced or metastatic non-small cell lung cancer.

In-licensing Agreement | 17/11/2026 | By News Bureau


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members